Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Seller: moluna, Greven, Germany
£ 137.63
Convert currencyQuantity: Over 20 available
Add to basketCondition: New. Dr. Parteek Prasher, an Associate Professor in the Department of Chemistry at the University of Petroleum & Energy Studies, possesses 8 years of research experience in medicinal chemistry and biomaterials. Leading a research team, he focuses on devel.
Published by Taylor & Francis Ltd, London, 2025
ISBN 10: 1032812591 ISBN 13: 9781032812595
Language: English
Seller: AussieBookSeller, Truganina, VIC, Australia
£ 131.29
Convert currencyQuantity: 1 available
Add to basketHardcover. Condition: new. Hardcover. This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.Provides an in-depth understanding of the epidemiology, etiology, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD)Delve into pathways responsible for COPD progression, conducting a detailed analysis of established biomarkers and potential targets in contemporary COPD therapyOffer insights into ongoing treatment modalities, evaluating their efficacy, drawbacks, and proposing prospective solutions to counter the setbacks of COPD therapySystematically organizes information on state-of-the-art drug delivery technologies and novel formulations designed to enhance drug deposition and absorption in COPD lungsPresents a methodical explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems This book reviews the epidemiology, etiology, ongoing clinical trials, emerging personalized therapies, advanced drug delivery systems, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Published by Taylor & Francis Ltd, London, 2025
ISBN 10: 1032812591 ISBN 13: 9781032812595
Language: English
Seller: CitiRetail, Stevenage, United Kingdom
Hardcover. Condition: new. Hardcover. This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.Provides an in-depth understanding of the epidemiology, etiology, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD)Delve into pathways responsible for COPD progression, conducting a detailed analysis of established biomarkers and potential targets in contemporary COPD therapyOffer insights into ongoing treatment modalities, evaluating their efficacy, drawbacks, and proposing prospective solutions to counter the setbacks of COPD therapySystematically organizes information on state-of-the-art drug delivery technologies and novel formulations designed to enhance drug deposition and absorption in COPD lungsPresents a methodical explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems This book reviews the epidemiology, etiology, ongoing clinical trials, emerging personalized therapies, advanced drug delivery systems, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
£ 150.70
Convert currencyQuantity: 10 available
Add to basketCondition: As New. Unread book in perfect condition.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
£ 151.59
Convert currencyQuantity: 10 available
Add to basketCondition: New.
Published by Taylor & Francis Ltd Jun 2025, 2025
ISBN 10: 1032812591 ISBN 13: 9781032812595
Language: English
Seller: AHA-BUCH GmbH, Einbeck, Germany
£ 168.20
Convert currencyQuantity: 2 available
Add to basketBuch. Condition: Neu. Neuware - This book reviews the epidemiology, etiology, ongoing clinical trials, emerging personalized therapies, advanced drug delivery systems, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.
Published by Taylor & Francis Ltd, 2025
ISBN 10: 1032812591 ISBN 13: 9781032812595
Language: English
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
£ 178.06
Convert currencyQuantity: Over 20 available
Add to basketHardback. Condition: New. New copy - Usually dispatched within 4 working days. 690.
Published by Taylor & Francis Ltd, London, 2025
ISBN 10: 1032812591 ISBN 13: 9781032812595
Language: English
Seller: Grand Eagle Retail, Mason, OH, U.S.A.
£ 153.61
Convert currencyQuantity: 1 available
Add to basketHardcover. Condition: new. Hardcover. This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.Provides an in-depth understanding of the epidemiology, etiology, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD)Delve into pathways responsible for COPD progression, conducting a detailed analysis of established biomarkers and potential targets in contemporary COPD therapyOffer insights into ongoing treatment modalities, evaluating their efficacy, drawbacks, and proposing prospective solutions to counter the setbacks of COPD therapySystematically organizes information on state-of-the-art drug delivery technologies and novel formulations designed to enhance drug deposition and absorption in COPD lungsPresents a methodical explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems This book reviews the epidemiology, etiology, ongoing clinical trials, emerging personalized therapies, advanced drug delivery systems, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 328 pages. 10.00x7.00x10.00 inches. In Stock.
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 328 pages. 10.00x7.00 inches. In Stock. This item is printed on demand.